Quick Answer
Enveric Biosciences, Inc. reported Total Assets of $5.10 million for fiscal year 2025.
Enveric Biosciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $5.10M | +65.3% |
| 2024 | $3.08M | -28.3% |
| 2023 | $4.30M | -78.0% |
| 2022 | $19.55M | -26.8% |
| 2021 | $26.72M | +552.2% |
| 2020 | $4.10M | +3665.9% |
| 2019 | $108.8K | -99.6% |
| 2018 | $29.64M | -43.2% |
| 2017 | $52.20M | +32.1% |
| 2016 | $39.51M | +776850.3% |
| 2014 | $5.1K | +13.8% |
| 2013 | $4.5K | -20.2% |
| 2012 | $5.6K | -75.1% |
| 2011 | $22.4K | +1893.8% |
| 2010 | $1.1K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.36M | -8.9% | +22.9% |
| June 30, 2025 | $3.55M | -41.4% | -30.5% |
| March 31, 2025 | $5.10M | -42.3% | +65.5% |
| December 31, 2024 | $3.08M | -28.3% | -35.7% |
| September 30, 2024 | $4.79M | -27.6% | -20.8% |
| June 30, 2024 | $6.05M | -38.3% | -31.6% |
| March 31, 2024 | $8.85M | -44.2% | +105.8% |
| December 31, 2023 | $4.30M | -78.0% | -35.0% |
- Enveric Biosciences, Inc. showed an increase of +65.3% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Enveric Biosciences, Inc.’s total assets has grown by 452470.2% (from $1.1 thousand to $5.10 million).
- The most recent figure is from Enveric Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: